The Ninth Annual Pharmacogenetics in Psychiatry Meeting
第九届精神病学药物遗传学年会
基本信息
- 批准号:8626448
- 负责人:
- 金额:$ 4.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-02 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAdverse effectsAntidepressive AgentsAntipsychotic AgentsAreaAwardCaringClinicalClinical TrialsDataDevelopmentEducational GrantsEvaluationFeesFinancial SupportFundingGenesGeneticGrowthHospitalsIndustryMediatingMedicineMentally Ill PersonsMolecularNational Institute of Mental HealthNew York CityPatientsPharmacogeneticsPsychiatryPsychotropic DrugsRequest for ApplicationsResearchResearch PersonnelResourcesScheduleSourceTravelVariantWorkbasecareerclinical practicegenome wide association studyinterdisciplinary approachinterestmeetingsnovelprogramspublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): The annual Pharmacogenetics in Psychiatry (PIP) meeting has provided a unique forum for the presentation and discussion of new developments in the field of psychiatry pharmacogenetics for the past eight years. Previous meetings have been highlighted by discussion of topics including: prediction of clinical response to antipsychotic and antidepressant drugs; genes associated with the development of adverse side effects; novel statistical approaches; and most recently, the implication of genome-wide association (GWAS) approaches for pharmacogenetics. Moreover, the meeting has brought together investigators working in diverse areas of research, from molecular geneticists to clinical trial investigators, from academia and industry in order to engender true interdisciplinary approaches to the problem of variation in clinical response to psychotropic drugs. The meetings have been highly successful as evidenced by continued growth in participation, excellent evaluations from meeting attendees, and the number of collaborative efforts that have grown out of meeting participation.
The prior PIP meetings have taken place in New York City with pooled support from a variety of sources: The Zucker Hillside Hospital, industry supported unrestricted educational grants, and registration fees. Because we believe that this program should have stable, independent financial support on an ongoing basis, in this application, we request support from the NIMH to enable us to continue this meeting in the face of declining financial support from other resources. Moreover, we hope to provide Travel Awards to deserving new investigators interested in developing research careers in this rapidly developing field. Therefore, in this application, we seek support for additional five years of funding for the annual PIP meeting, with the next meeting scheduled in New York City, April 23 & 24, 2010.
PUBLIC HEALTH RELEVANCE: Psychiatric pharmacogenetics is a rapidly evolving field of research that aims to identify genetic factors mediating the variation in psychotropic drug response. The introduction of pharmacogenetics into clinical practice would have significant impact on the care of mentally ill patients and the PIP meeting serves to provide a dedicated forum for the presentation and discussion of the latest data in this area of "personalized medicine".
描述(由申请人提供):精神病学药物遗传学年会(PIP)为过去八年来精神病学药物遗传学领域的新发展提供了一个独特的论坛。以前的会议已经强调了主题的讨论,包括:预测抗精神病和抗抑郁药物的临床反应;与不良副作用的发展相关的基因;新的统计方法;最近,全基因组关联(GWAS)方法对药物遗传学的影响。此外,会议还汇集了来自不同研究领域的研究人员,从分子遗传学家到临床试验研究人员,从学术界到工业界,以产生真正的跨学科方法来解决精神药物临床反应的变化问题。这些会议非常成功,这体现在参与人数的持续增长、与会者的出色评价以及因参与会议而产生的协作努力的数量。
以前的PIP会议在纽约市举行,得到了各种来源的共同支持:Zucker希尔赛德医院、工业界支持的无限制教育赠款和登记费。因为我们相信,这个计划应该有稳定的,独立的财政支持,在此申请,我们要求从NIMH的支持,使我们能够继续这一会议,面对其他资源的财政支持下降。此外,我们希望提供旅行奖,值得有兴趣在这个快速发展的领域发展研究事业的新的调查人员。因此,在本申请中,我们寻求为年度PIP会议提供额外五年的资金支持,下一次会议定于2010年4月23日和24日在纽约市举行。
公共卫生相关性:精神药物遗传学是一个快速发展的研究领域,旨在确定介导精神药物反应变化的遗传因素。将药物遗传学引入临床实践将对精神病患者的护理产生重大影响,PIP会议为介绍和讨论“个性化医疗”这一领域的最新数据提供了一个专门的论坛。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Ninth Annual Pharmacogenetics in Psychiatry Meeting report.
第九届精神病学药物遗传学会议报告。
- DOI:10.1097/ypg.0b013e328341e07e
- 发表时间:2011
- 期刊:
- 影响因子:0.9
- 作者:Aitchison,KatherineJ;Malhotra,AnilK
- 通讯作者:Malhotra,AnilK
The 12th Annual Pharmacogenetics in Psychiatry meeting report.
第 12 届精神病学药物遗传学年度会议报告。
- DOI:10.1097/ypg.0000000000000041
- 发表时间:2014
- 期刊:
- 影响因子:0.9
- 作者:Zhang,Jian-Ping;Aitchison,KatherineJ;Malhotra,AnilK
- 通讯作者:Malhotra,AnilK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anil K Malhotra其他文献
The FEZ1 Gene Shows No Association to Schizophrenia in Caucasian or African American Populations
FEZ1 基因在高加索人或非裔美国人人群中与精神分裂症无关联
- DOI:
10.1038/sj.npp.1301177 - 发表时间:
2006-08-16 - 期刊:
- 影响因子:7.100
- 作者:
Colin A Hodgkinson;David Goldman;Francesca Ducci;Pamela DeRosse;Daniel A Caycedo;Emily R Newman;John M Kane;Alec Roy;Anil K Malhotra - 通讯作者:
Anil K Malhotra
Anil K Malhotra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anil K Malhotra', 18)}}的其他基金
Striatal Connectivity and Clinical Outcome in Psychosis
纹状体连接性和精神病的临床结果
- 批准号:
10369158 - 财政年份:2021
- 资助金额:
$ 4.6万 - 项目类别:
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia
难治性精神分裂症临床反应的连通性生物标志物
- 批准号:
9239186 - 财政年份:2017
- 资助金额:
$ 4.6万 - 项目类别:
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia
难治性精神分裂症临床反应的连通性生物标志物
- 批准号:
9891084 - 财政年份:2017
- 资助金额:
$ 4.6万 - 项目类别:
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia
难治性精神分裂症临床反应的连通性生物标志物
- 批准号:
10084173 - 财政年份:2017
- 资助金额:
$ 4.6万 - 项目类别:
Striatal Connectivity and Clinical Outcome in Psychosis
纹状体连接性和精神病的临床结果
- 批准号:
9920775 - 财政年份:2016
- 资助金额:
$ 4.6万 - 项目类别:
Striatal Connectivity and Clinical Outcome in Psychosis
纹状体连接性和精神病的临床结果
- 批准号:
9331735 - 财政年份:2016
- 资助金额:
$ 4.6万 - 项目类别:
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)
2/3-精神分裂症神经生物学社会过程倡议
- 批准号:
9110619 - 财政年份:2014
- 资助金额:
$ 4.6万 - 项目类别:
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)
2/3-精神分裂症神经生物学社会过程倡议
- 批准号:
8890889 - 财政年份:2014
- 资助金额:
$ 4.6万 - 项目类别:
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)
2/3-精神分裂症神经生物学社会过程倡议
- 批准号:
8758171 - 财政年份:2014
- 资助金额:
$ 4.6万 - 项目类别:
2/2-Pramipexole in Bipolar Disorder: Targeting Cognition
2/2-普拉克索治疗双相情感障碍:针对认知
- 批准号:
8759812 - 财政年份:2014
- 资助金额:
$ 4.6万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




